[1]
S. Krishnan, B. C. S., and S. P. Mohamedali, “A cost-effective analysis of various disease modifying anti-rheumatic drugs for patients with Rheumatoid Arthritis”, Int J Basic Clin Pharmacol, vol. 7, no. 6, pp. 1153–1159, May 2018.